# 21 U.S.C. 355b Adverse-event reporting

21 U.S.C. 355b Adverse-event reporting, “Adverse-event reporting”, is a U.S. Code section of [Part A—Drugs and Devices](https://ontology.bommaritollc.com/id/01a0f06c-cb97-754b-b68a-a66a473f5a0d); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f06c-ccdb-761d-a3bd-6e2fa6efe1f6>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f06c-cb65-7672-8fda-c39517ff08c0) › [Chapter 9—Federal Food, Drug, and Cosmetic Act](https://ontology.bommaritollc.com/id/01a0f06c-cb91-72e0-858b-060e8c845f23) › [Subchapter V—Drugs and Devices](https://ontology.bommaritollc.com/id/01a0f06c-cb96-7040-b454-c8f18e0e95cb) › [Part A—Drugs and Devices](https://ontology.bommaritollc.com/id/01a0f06c-cb97-754b-b68a-a66a473f5a0d)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [usc-section 21 U.S.C. 355b](https://ontology.bommaritollc.com/id/01a0f06c-ccdc-7622-b131-67507287a196)
- `eli:cites`:
  - [Subchapter I—Short Title](https://ontology.bommaritollc.com/id/01a0f06c-cb93-728d-8bec-aa786c4f42b1)
  - [21 U.S.C. 355 New drugs](https://ontology.bommaritollc.com/id/01a0f06c-ccd6-7038-b7ea-5f9e1b3b3f50)
  - [21 U.S.C. 355a Pediatric studies of drugs](https://ontology.bommaritollc.com/id/01a0f06c-ccd9-779c-b02d-f70feff4a7a0)
  - [21 U.S.C. 393a Office of Pediatric Therapeutics](https://ontology.bommaritollc.com/id/01a0f06c-ce2b-704c-a63d-dfbc74735d17)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/USCODE-2024-title21/USCODE-2024-title21-chap9-subchapV-partA-sec355b](https://ontology.bommaritollc.com/id/01a0f06c-ccdb-761d-a3bd-6e2e31bc8828)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f06c-d14f-77b2-854b-a30e3bf31f70)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d2-2d3e-7455-9f6b-b1862037ad8c)
  - [evidence from https://www.govinfo.gov/link/uscode/21/355b?type=usc&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f15-fe22-77c0-9a58-7e743a76e871)
- `schema:isPartOf`: [Part A—Drugs and Devices](https://ontology.bommaritollc.com/id/01a0f06c-cb97-754b-b68a-a66a473f5a0d)
- `schema:legislationIdentifier`: 21 U.S.C. 355b
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [U.S. Code section](https://ontology.bommaritollc.com/vocab/leg/uscSection)
- `schema:name`: Adverse-event reporting
- `schema:url`: [https://www.govinfo.gov/link/uscode/21/355b?type=usc&year=mostrecent&link-type=details](https://www.govinfo.gov/link/uscode/21/355b?type=usc&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 U.S.C. 355b Adverse-event reporting

## Elsewhere

- [Official page](https://www.govinfo.gov/link/uscode/21/355b?type=usc&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/USCODE-2024-title21/USCODE-2024-title21-chap9-subchapV-partA-sec355b) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Amended by (1; `eli:amends`):
  - [Pub. L. 108-155](https://ontology.bommaritollc.com/id/01a0f06c-d315-7199-af3d-70f79086f2af)
- Its changes, from (1; `eli:changes`):
  - [Pub. L. 107-109](https://ontology.bommaritollc.com/id/01a0f06c-d2a6-749e-9a14-41abc3b35120)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f06c-ccdb-761d-a3bd-6e2fa6efe1f6.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f06c-ccdb-761d-a3bd-6e2fa6efe1f6.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f06c-ccdb-761d-a3bd-6e2fa6efe1f6.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f06c-ccdb-761d-a3bd-6e2fa6efe1f6)
Cite as: 21 U.S.C. 355b Adverse-event reporting. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f06c-ccdb-761d-a3bd-6e2fa6efe1f6
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
